ADIPOQ and type 2 diabetes mellitus: Although the mechanism for reduced adiponectin during obesity and T2DM has been attributed, in part, to an increase in local TNF-α in adipose tissue [44], strain-related variability of adiponectin gene expression and plasma has been previously documented [45].